Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGM0504 in Chinese Non-diabetic Overweight or Obese Participants
NCT06704581Phase 3Completed
- Sponsor
- BrightGene Bio-Medical Technology
- Start
- Oct 2024
- Primary completion
- Mar 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of BGM0504 in Overweight, obesity, sponsored by BrightGene Bio-Medical Technology. Started Oct 2024; status: completed.
02
Drugs
BGM0504
03
Conditions
Overweightobesity
Beyond the preview
Go deeper on NCT06704581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06704581.